Automate, innovate, adapt

Published May 22, 2025 | Updated May 28, 2025

Listen to article

KEY INSIGHTS

69% have implemented some form of automation

BUT ONLY 9% have fully integrated it across their operations

56% identify high labor, operational costs as the primary obstacles to bringing manufacturing back to their home countries

42% cite regulatory compliance as top barrier to commercializing medical products

31% identified personalized medicine as the most challenging manufacturing trend in 2025

Post-COVID supply chain adaptations: Companies are redefining supply chain strategies to mitigate persistent disruptions

AI and predictive analytics: Manufacturers are increasingly leveraging AI to enhance quality assurance, operational efficiency

Regulatory compliance: Best practices to streamline complexity, reduce costs

Automation: Addressing workforce readiness, cost barriers with actionable strategies

Reshoring: Overcoming operational challenges through cost optimization, training programs

The medical and life sciences industry stands at a pivotal crossroads, where challenges such as regulatory hurdles and labor shortages converge with opportunities in automation, AI, and personalized medicine. Learn more in the full report. https://mls.ascentialtech.com/wp-content/uploads/2025/03/0225-IS-Ascential-MLS-State-of-Industry-Report-3.pdf

Check out more from this issue and find your next story to read.